Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
27
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
EZZ Life Science Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US Rebranding And New Product Launches Will Broaden Global Reach
Key Takeaways Expansion into the US and new product launches are set to drive significant revenue growth and enhance market share. Improved operational efficiency and new distribution channels indicate increased profitability and promising future financial performance.
View narrative
AU$5.00
FV
48.2% undervalued
intrinsic discount
15.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
9 days ago
author updated this narrative
Vanda Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expanding Global CNS And Orphan Therapies Will Unlock Future Potential
Key Takeaways Expansion of new product launches and increased sales efforts are driving strong growth in psychiatric and neurological treatment markets globally. Advancing a diverse pipeline in CNS and rare diseases reduces reliance on older products and supports long-term profitability through market exclusivity and improved margins.
View narrative
US$12.67
FV
62.5% undervalued
intrinsic discount
28.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
9 days ago
author updated this narrative
Alcoa
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Tariff Volatility And Recycled Materials Will Erode Primary Aluminum Margins
Key Takeaways Rising use of recycled aluminum and competitive lightweight materials, plus global supply growth, threaten Alcoa's long-term demand and the reliability of growth projections. Ongoing tariff volatility, regulatory pressures, operational bottlenecks, and limited production flexibility could compress margins and elevate future costs.
View narrative
US$33.55
FV
5.6% undervalued
intrinsic discount
2.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
9 days ago
author updated this narrative
ArcelorMittal
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Europe Reforms And Green Steel Investments Will Open Markets
Key Takeaways Strategic decarbonization projects and investments in green steel are positioning the company to benefit from premium demand and expanding margins. Expansion in high-growth regions and asset optimization, including divestments and acquisitions, are driving improved profitability and earnings per share.
View narrative
€30.71
FV
5.1% undervalued
intrinsic discount
4.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
EHang Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
China's Regulatory Milestone Will Unlock Urban Air Mobility Expansion
Key Takeaways Regulatory breakthroughs and global partnerships position EHang for accelerated growth and diversification in urban air mobility markets. Expanding into integrated services and innovation in autonomous flight strengthens recurring revenue and supports higher margins and earnings stability.
View narrative
US$27.32
FV
32.3% undervalued
intrinsic discount
70.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
38
users have followed this narrative
9 days ago
author updated this narrative
Tuya
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Advancing AI, Hardware And Ecosystems Will Shape Our Future
Key Takeaways Expansion into hardware solutions and AI R&D could drive smart device penetration and boost revenue growth across various sectors. Focus on global AIoT ecosystem and strategic international expansion is key for sustained competitive advantages and revenue growth.
View narrative
US$3.28
FV
23.7% undervalued
intrinsic discount
11.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
9 days ago
author updated this narrative
Transocean
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Rising Global Energy Demand Will Unlock Offshore Opportunities
Key Takeaways Tightening rig market and rising demand are boosting Transocean's pricing power, revenue potential, and ability to secure high-margin contracts. Strong contract pipeline and industry consolidation provide cash flow stability while supporting margin expansion and improved balance sheet strength.
View narrative
US$3.92
FV
22.5% undervalued
intrinsic discount
0.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
9 days ago
author updated this narrative
Core Scientific
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
HPC Expansion And Diversified Contracts Will Create Future Resilience
Key Takeaways Reallocating resources from Bitcoin mining to HPC infrastructure could drive future growth amid rising data center demands and diversified clientele. Debt restructuring and 0% interest funding improve growth potential and operational efficiencies through strategic hires, enhancing financial stability and earnings.
View narrative
US$18.45
FV
26.6% undervalued
intrinsic discount
59.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
43
users have followed this narrative
9 days ago
author updated this narrative
Neuren Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
DAYBUE And NNZ-2591 Will Expand Markets While Facing Regulatory Risks
Key Takeaways Strong financial position and partnerships reduce the need for capital raising, protecting margins and earnings. International expansion and R&D investments present significant long-term growth and valuation opportunities.
View narrative
AU$24.87
FV
30.9% undervalued
intrinsic discount
-8.22%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
48
users have followed this narrative
9 days ago
author updated this narrative
Value any company in seconds
Popular companies